Assessment of LncRNA CASC2 and TUG1 expression in Hepatocellular Carcinoma
Noha Salah Refai Ibrahim;
Abstract
H
CC is a public health priority worldwide. It represents the fifth most common cancer and the third leading cause of cancer related death. In Egypt, it is the second most common malignancy after bladder cancer in men and breast cancer in women and the second most common cause of death in men.
High morbidity observed in HCC is majorly attributed to lack of early detection markers and poor prognosis. Hence, there is an obvious need to diagnose HCC using novel non-invasive and sensitive biomarkers in order to accurately identify the high-risk population for optimal treatments and minimize unnecessary invasive procedures.
CC is a public health priority worldwide. It represents the fifth most common cancer and the third leading cause of cancer related death. In Egypt, it is the second most common malignancy after bladder cancer in men and breast cancer in women and the second most common cause of death in men.
High morbidity observed in HCC is majorly attributed to lack of early detection markers and poor prognosis. Hence, there is an obvious need to diagnose HCC using novel non-invasive and sensitive biomarkers in order to accurately identify the high-risk population for optimal treatments and minimize unnecessary invasive procedures.
Other data
| Title | Assessment of LncRNA CASC2 and TUG1 expression in Hepatocellular Carcinoma | Other Titles | تقييم مستوى الحمض الريبوزي الطويل الغير ناسخ CASC2 وTUG1 فى سرطان الكبد | Authors | Noha Salah Refai Ibrahim | Issue Date | 2019 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.